Related Experiment Video

Updated: May 29, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

[Therapeutic strategy against gliomas based on their molecular biological nature]

Yuichi Hirose1

  • 1Department of Neurosurgery, Fujita Health University, Kutsukake-cho, Toyoake-city, Aichi, Japan.

No Shinkei Geka. Neurological Surgery
|August 30, 2011
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Related Experiment Videos

Last Updated: May 29, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Articles linked to this work by shared authors, journal, and citation graph.

Refining reperfusion assessment with flat-panel detector CT: association with final infarct volume after endovascular thrombectomy.

European stroke journal·2026

Working conditions, career barriers and perceived equity among neuro-oncology professionals: insights from the Japan society for neuro-oncology (JSNO) gender equality and diversity committee survey.

International journal of clinical oncology·2026

Robot-Assisted Transoral Trans-hard Palate Corridor to the Ventral Skull Base: A Cadaveric Feasibility Study.

World neurosurgery·2026

Ependymoma-like tumor with mesenchymal differentiation harboring ZFTA::NCOA2 fusion: a case report.

Brain tumor pathology·2026

Normalized air/brain volume ratio (Air-Brain Index) as a postoperative marker of delayed chronic subdural hematoma after clipping of unruptured cerebral aneurysms.

Neurosurgical review·2026

Cadaveric Feasibility of Robot-Assisted V3-Radial Artery-P2 Bypass.

Operative neurosurgery (Hagerstown, Md.)·2026

[Role of Cerebral Hemodynamic and Metabolic Measurements in the Management of Ischemic Cerebrovascular Disease].

No shinkei geka. Neurological surgery·2026

[The Next Frontier of Medical AI in Brain Tumor Care:From Prediction to Trust].

No shinkei geka. Neurological surgery·2026

[Translational Research in Brain Tumors:Development towards Integrated Precision Medicine].

No shinkei geka. Neurological surgery·2026

[Genomic and Epigenomic Research on Brain Tumors].

No shinkei geka. Neurological surgery·2026

[Cancer Genomic Medicine in Neuro-Oncology Practice].

No shinkei geka. Neurological surgery·2026

[Recent Advances in the Treatment of Craniopharyngioma:A Breakthrough in Molecular Targeted Therapy].

No shinkei geka. Neurological surgery·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us